Author: Haylee Boyens, Medical Student, University of Auckland, New Zealand; Chief Editor: Dr Amanda Oakley, Dermatologist, Hamilton, New Zealand, December 2014. Latest update by Dr Jannet Gomez, Postgraduate student in Clinical Dermatology, Queen Mary University London, United Kingdom, July 2016.
Gangrene is the localised death of body tissue. Wet gangrene is gangrene due to necrotisingbacterial infections, including necrotising fasciitis. Wet gangrene should be distinguished from 'dry' gangrene, which is due to ischaemia.
What causes necrotising bacterial infections?
Necrotising bacterialinfections can occur via any break in the skin or internal organ. They are caused by 3 main bacterial subgroups:
1. Polymicrobial necrotising infection
Polymicrobial necrotising infections often involve a mix of:
Gram-positive cocci
Gram-negative rods
Anaerobes, including clostridial species.
Polymicrobial necrotising infections tend to affect the trunk and perineum.
Patients with these infections usually have a history of other medical problems, especially diabetes, and are likely to be older adults. The initial injury to the skin may have been unnoticed.
Gas gangrene
Gas gangrene is particularly severe and is most often due to Clostridium perfringens, which can rapidly proliferate in injured muscles. This organism is ubiquitous in soil and dust. Gas gangrene was very prevalent in World War 1, complicating 6% of open fractures and 1% of all open wounds. Clostridia release alpha, beta and other toxins, which induce blood clotting at the site of the infection and result in myonecrosis (death of muscle tissue). Reduced blood flow, localised ischaemia and lowered pH result in a favourable environment for other bacteria to grow. The gas is composed of nitrogen, oxygen, hydrogen, hydrogen sulfide and carbon dioxide. It spreads within the muscle fibres allowing rapid spread of infection.
Patients with streptococcal and staphylococcal infections are likely to be younger and in better general health than those with polymicrobial infections. The route of entry usually follows trauma, including surgery and intravenous drug (ab)use. M proteins produced by GAS allow the bacteria to adhere to tissue and evade the immune system. M protein can also activate T lymphocytes, which can lead to an inflammatory shock response.
3. Gram-negative marine organisms
Marine organisms such as Vibrio vulnificus are rare causes of gangrene and have mostly been reported in warm coastal regions. Route of infection can be through an open wound exposed to water, or via ingestion of infected oysters. Systemictoxicity tends to occur early.
Anticoagulants, especially the combination of warfarin (coumadin) and heparin.
What are the clinical features of necrotising bacterial infections?
The clinical features of necrotising infections depend upon the location and cause.
Necrotising infections frequently resemble cellulitis or an abscess initially, but progress to discolouration (blue to black), foul-smelling discharge, and/or numbness. If the affected area is internal, symptoms may include confusion, fever, gas in the tissues under the skin, low blood pressure and persistent or severe pain.
The early signs of gangrene that should result in an urgent investigation are:
Bullae (blisters), often haemorrhagic
Ecchymosis (bruising) preceding necrosis (death of tissue)
Crepitation (gas in the tissues)
Cutaneous anaesthesia (numbness).
Less specific signs that should increase clinical suspicion of necrotising infection include:
Pain out of proportion to the signs of disease
Swelling that extends beyond the area of reddened skin
Systemic toxicity
Progression of infection despite treatment with antibiotics.
Necrotising skin infections may progress rapidly to wet gangrene, unlike cellulitis or abscess.
Necrotising skin infections with gangrene
Necrotising skin infection
Necrotising skin infection
Necrotising skin infection
Investigations in necrotising infections
Laboratory tests
Blood cultures should be undertaken to identify specific organisms involved in the infection.
The table below was developed as a risk indicator for necrotising fasciitis by Wong et al. in 2004. Scores ≥6 were found to have a 92% positive predictive value and a 96% negative predictive value.
Elements of the laboratory risk indicator for necrotizing fasciitis (LRINEC) score
Laboratory marker
Scoring evaluation
CRP (mg/dL)
150 = 0 points
> 150 = 4 points
WBC (per mm3)
15 = 0 points
15–25 = 1 point
> 25 = 2 points
Hb (g/dL)
> 13.5 = 0 points
11.6–13.5 = 1 point
11.5 = 2 points
Serum sodium
> 135 = 0 points
135 = 2 points
Serum creatinine
≤ 1.6 = 0 points
> 1.6 = 2 points
Serum glucose
180 = 0 points
> 180 = 1 point
CRP: C-reactive protein; Hb: haemoglobin.
Imaging
Imaging has a limited role in the diagnosis of infectious gangrene.
Plain film X-ray can demonstrate subcutaneous emphysema (gas under the skin) sometimes present in clostridial infections.
CT scanning may show fascial thickening, oedema, subcutaneous gas, and abscess formation.
MRI scanning shows similar findings to CT but is less specific as tissue enhancement may mimic other inflammatory processes.
Surgical exploration
Surgery is the gold standard for diagnosing necrotising fasciitis — the fascia separates from surrounding tissue.
Small incisions with local exploration are useful for identifying necrotic tissue in other cases.
What is the treatment for established wet gangrene?
Treatment of gangrene depends on location and cause, but is centred around:
Hyperbaric oxygen, especially in patients with diabetes or peripheral vascular disease.
Intravenous immunoglobulin – this may limit the inflammatory response by binding staphylococcal and streptococcal toxins.
Treatment of underlying conditions such as diabetes.
The incidence of wartime gas gangrene has markedly reduced with identification and isolation of cases, and early debridement, amputation and supportive treatment.
What is the prognosis for wet gangrene?
Prognosis in wet gangrene depends on the extent of disease, the underlying cause and the timing of appropriate treatment.
Anaya et.al have constructed a clinical score to predict patient outcomes for infective gangrene based on several clinical criteria:
Heart rate > 110 beats per minute
Temperature < 36 degrees Celsius
Serum creatinine > 1.5 mg/dL
Age > 50 years
WBC > 40 000 per uL
Haematocrit > 50%
Patients with few of these findings had a 6% risk of death in this study, while patients with several findings had up to an 88% risk of death. Prognosis can vary widely due to the aggressive nature of gangrene if treatment is not accessed early.
References
Hakkarainen TW, Kopari NM, Pham TN, Evans HL. Necrotising soft tissue infections: Review and current concepts in treatment, systems of care, and outcomes. Current Problems in Surgery. 2014 Aug;51(8):344–62. doi: 10.1067. PubMed
C. Wong, L. Khin, K. Heng, K. Tan, C. Low. The LRINEC (laboratory risk indicator for necrotising fasciitis) score: a tool for distinguishing necrotising fasciitis from other soft-tissue infections. Crit Care Med. 2004 Jul;32(7):1535–41. doi: 10.1097/01.ccm.0000129486.35458.7d. PubMed
Anaya DA, Bulger EM, Kwon YS, Kao LS, Evans H, Nathens AB. Predicting death in necrotizing soft tissue infections: a clinical score. Surg Infect (Larchmt). 2009 Dec;10(6):517–22. doi: 10.1089/sur.2008.112. PubMed
Oncel S, Arsoy ES. Rapidly developing gas gangrene due to a simple puncture wound. Pediatr Emerg Care. 2010 Jun;26(6):434–5. doi: 10.1097/PEC.0b013e3181e15e4f. PubMed
Ying Z, Zhang M, Yan S, Zhu Z. Gas gangrene in orthopaedic patients. Case Rep Orthop. 2013;2013:942076. doi: 10.1155/2013/942076. Epub 2013 Oct 28. PubMed
Hirn M. Hyperbaric oxygen in the treatment of gas gangrene and perineal necrotizing fasciitis. A clinical and experimental study. Eur J Surg Suppl. 1993;(570):1–36. PubMed
Bhutani S, Vishwanath G. Hyperbaric oxygen and wound healing. Indian J Plast Surg. 2012 May-Aug; 45(2): 316–324. doi: 10.4103/0970-0358.101309. PubMed Central
Gilead L, Mumcuoglu KY, Ingber A. The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients. J Wound Care. 2012 Feb;21(2):78, 80, 82–85. doi: 10.12968/jowc.2012.21.2.78. PubMed PMID: 22584527.